McKesson Corporation (MCK) Finalizes Purchase of Core Ventures

McKesson Corporation (NYSE:MCK) announced that it has finalized the purchase of a majority stake in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative services company founded by Florida Cancer Specialists & Research Institute, LLC (FCS).

This acquisition supports the growth of community-based cancer care and strengthens McKesson’s efforts to advance clinical research, improve outcomes, and increase access to quality treatment in local communities.

McKesson Corporation (MCK) Finalizes Purchase of Core Ventures

A successful pharmacist in front of shelves of drugs in a community-based oncology pharmacy.

McKesson Corporation (NYSE:MCK) now holds roughly 70% of Core Ventures in a deal valued at around $2.49 billion, while FCS physicians retain the remaining 30%.

FCS, which includes over 250 doctors and 280 advanced practice providers across nearly 100 Florida locations, will continue to operate independently and has joined McKesson’s The US Oncology Network, a leading organization focused on enhancing local, affordable cancer care and improving patient outcomes.

McKesson Corporation (NYSE:MCK) is a leading provider of healthcare services, committed to improving health outcomes for patients across the globe. The company collaborates with biopharmaceutical firms, healthcare providers, pharmacies, manufacturers, governments, and other partners to offer insights, products, and services that support greater access to high-quality, affordable care.

MCK has surged by over 26% since the start of 2025.

While we acknowledge the potential of MCK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MCK and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: Why These Energy Stocks Are Gaining This Week and 10 Best Income Stocks to Invest in Now

Disclosure. None.